Nestle is launching a new line of food for people who are eating less food. The company's new Vital Pursuit line of products is designed for people who are using Ozempic, Wegovy, and similar weight-loss drugs, known as GLP-1 medications, Fox Business reports. In a news release, the company said the "products are high in protein, a good source of fiber, contain essential nutrients, and they are portion-aligned to a weight loss medication user's appetite." Nestle said the products will meet consumers' need for a "sharper focus on portion control and nutrient balance" with a "variety of frozen formats such as bowls with whole grains or protein pasta, sandwich melts, and pizzas."
The company said the products will go on sale at "select retailers" later this year, with a suggested price of $4.99 or less. Execs at other companies, including Walmart, have also noticed a shift in consumer habits with the rise of GLP-1 medications. JPMorgan predicts that the number of people taking the drugs, originally prescribed for managing Type 2 diabetes, will reach 30 million by 2030, CBS News reports. Last year, Nestle CEO Mark Schneider said the company is also working on supplements to help people taking the medications get enough nutrients. (More Ozempic stories.)
,
uBlock 
,
and
Ghostery 
)
